Additional cytogenetic changes and previous genotoxic exposure predict unfavorable prognosis in myelodysplastic syndromes and acute myeloid leukemia with der(1;7)(q10;p10)
- 31 March 2006
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 165 (2) , 161-166
- https://doi.org/10.1016/j.cancergencyto.2005.09.003
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 19 references indexed in Scilit:
- Rare recurring balanced chromosome abnormalities in therapy‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop†Genes, Chromosomes and Cancer, 2002
- Myelodysplastic syndrome: review of the cytogenetic and molecular dataCritical Reviews in Oncology/Hematology, 2001
- The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sexBritish Journal of Haematology, 2001
- Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: Experience from the Copenhagen series updated to 180 consecutive casesGenes, Chromosomes and Cancer, 1998
- Molecular features of primary MDS with cytogenetic changesLeukemia Research, 1998
- Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemiaBlood, 1990
- Translocation (1;7)(p11;p11): A new myeloproliferative hematologic entityCancer Genetics and Cytogenetics, 1985
- Translocation 1;7 in hematologic disorders: A brief review of 22 casesCancer Genetics and Cytogenetics, 1985
- Translocation 1;7 in dyshematopoiesis: Possibly induced with a nonrandom geographic distributionCancer Genetics and Cytogenetics, 1984
- An Identical Translocation between Chromosome 1 and 7 in Three Patients with Myelofibrosis and Myeloid MetaplasiaBritish Journal of Haematology, 1980